STIM

#3505
Neuronetics, Inc. - Common Stock
1.5 4 USD
-1.28%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.54
1.54
Year Range
0.80
4.82
Daily Change
-1.28%
Monthly Change
-9.41%
6 month change
+3.36%
Year Change
-60.71%
Previous Close
1.5 6
Open
1.5 4
Low
1.5 4
High
1.5 4
Volume
33
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 107.17 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.34
Price to sales ratio
0.65

Neuronetics, Inc. - Common Stock

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

News